Abstract
The prognostic role of in-hospital peak glycemia in patients with ST-elevation myocardial infarction (STEMI) has been previously reported. Goyal et al. [1] observed, in 30,536 STEMI patients, that average in-hospital glucose levels were a much stronger mortality predictor than diabetes history. In 252 non-diabetic STEMI patients submitted to percutaneous coronary intervention (PCI) [2], the poorer in-hospital glucose control was associated with the higher mortality; in particular peak glycemia>180mg/dl (>10mmol/l) was associated with the highest mortality, whereas patients with peak glycemia comprised between 140 and 180mg/dl (7.8 and 10mmol/l) exhibited intermediate mortality rates.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
